Al Mansour L, De Mestier L, Haissaguerre M, Afchain P, et al. Outcome on Mesenteric Mass Response of Small-Intestinal Neuroendocrine Tumors Treated by (177)Lu-DOTATATE Peptide Receptor Radionuclide Therapy: The MesenLuth Study, a National Study from the French Group of Endocrine Tumors and Endocan-RENATEN Networ J Nucl Med 2024;65:258-263.
PMID: 38212066